Autologous T cells are ex vivo transfected with synthetic mRNA encoding an HBV-specific T-cell receptor, leading to transient TCR expression that recognizes HBV peptide–HLA complexes on infected hepatocytes and triggers TCR signaling–mediated cytotoxicity (perforin/granzyme) for targeted elimination of HBV-infected cells.